Results 91 to 100 of about 35,954 (204)

Impact of dopants on X‑ray attenuation of 3D‑printed polymers for mammography and tomosynthesis spectra

Journal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background 3D‐printing enables the production of anthropomorphic breast phantoms for assessing image quality in digital mammography (DM) and breast tomosynthesis (DBT). 3D‐printing materials must be selected carefully to mimic breast tissue attenuation for clinical spectra.
Adrián Belarra, Irene Hernández‐Girón, María Castillo‐García, Peter Homolka, Margarita Chevalier   +4 more
wiley   +1 more source

Gold Nano Biosensing Technologies for Early Breast Cancer Diagnosis: Recent Progress and Future Perspectives

Advanced Sensor Research, Volume 5, Issue 8, August 2026.
Overview of gold nanomaterial‐based biosensing strategies for early breast cancer diagnosis. The figure illustrates the detection of multiple biomarker classes, including proteins, nucleic acids, circulating tumor cells (CTCs), and exosomes from biological samples such as blood, serum, and cell lysates using electrochemical, SPR, SERS, fluorescence ...
Akanksha Pawar, Muskan Leharwani, Deena Mohammed Bukhary, Garima Gupta, Khang Wen Goh, Amirhossein Sahebkar, Prashant Kesharwani   +6 more
wiley   +1 more source

Applications of Artificial Intelligence in Cancer Diagnosis and Treatment

Cancer Medicine, Volume 15, Issue 8, August 2026.
This review explores how AI and multimodal data fusion transform oncology through enhanced screening, precision diagnosis, and personalized therapy. By dissecting core challenges—including data bias and explainability—it provides a strategic framework for the digital transformation and ethical implementation of AI in clinical cancer care.
Yifeng Xie, Zixuan Wang, Zhiwen Zeng, Tongyao Xin, Shaofei Yuan, Feiwei Qin, Zhonglin Chen   +6 more
wiley   +1 more source

Advancing Tumor Treatment Through Artificial Intelligence and Mathematical Modeling: A Comprehensive Review

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Solid tumors emerge from uncontrolled cell division and interactions with neighboring cells that influence their growth and resistance to therapy. Anti‐cancer drugs are developed to disrupt these processes, but they often damage healthy cells, making treatment difficult to manage safely and effectively. As the global cancer
Mohsin Kamran, Abdul Majeed, A S M Rafiul Haque, Johari Yap Abdullah   +3 more
wiley   +1 more source

Co‐Designing Culturally Tailored Bowel, Cervical and Breast Cancer Screening Interventions With Migrant Communities: Towards Closing the Migration‐Related Cancer‐Equity Gap in New South Wales, Australia

Health Expectations, Volume 29, Issue 4, August 2026.
ABSTRACT Background Migrants in Australia experience persistent cancer‐equity gaps, with later‐stage diagnoses linked to low screening participation. This study aimed to co‐design cancer screening interventions with migrant and refugee communities to promote equitable participation and reduce disparities in bowel, cervical and breast cancer screening ...
Andre M. N. Renzaho, Sheetal Challam, Nina Hartcher, Mitchell Smith, Sandra Elhelw, Amanda Jayakody, Sarah McGill, Tracey A. O'Brien   +7 more
wiley   +1 more source

A Compact Spin‐Coated Graphene UWB Antenna for Breast Tumor Detection

Advanced Engineering Materials, Volume 28, Issue 14, 22 July 2026.
A compact, spin‐coated graphene ultra‐wideband patch antenna designed for breast tumor detection, capable of distinguishing between malignant and benign tumors. This innovative antenna can serve as an effective initial screening tool, particularly in resource‐limited settings such as rural areas, where access to advanced medical equipment like MRI and ...
Raja Rashidul Hasan, Shuvra Saha, Sumit Hassan Eshan, Rinku Basak, Md. Nahian Al Subri Ivan, Ahmed Murtuza Saleque, Raja Tariqul Hasan Tusher, Sadia Zabin, Md. Abdur Rahman, Yuen Hong Tsang   +9 more
wiley   +1 more source

Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity

International Journal of Cancer, Volume 159, Issue 2, Page 450-459, 15 July 2026.
What's new? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld, Magdalena Ríos‐Romero, Huma Dar, Tommy Fornander, Gizeh Perez‐Tenorio, Helena Fohlin, Olle Stål, Julia Tutzauer, Linda S. Lindström   +8 more
wiley   +1 more source

Radiologic imaging and its current importance in breast cancer management

Frontiers in Radiology
IntroductionThis study examines the approaches used for cancer screening in women, insisting on the roles of mammography, breast ultrasound, breast MRI, computed tomography (CT), and positron emission tomography.
Nisha Dagar, Monu Sarin, Piyush Yadav, Rajdeep Thidwar   +3 more
doaj   +1 more source

Breast cancer screening in France: results of the EDIFICE survey

International Journal of Medical Sciences, 2008
Background: The EDIFICE survey aimed to investigate the compliance of the general population to the screening tests available in France for the 4 most common cancers: breast, colorectal, prostate and lung.
X Pivot, O Rixe, JF Morere, Y Coscas, L Cals, M Namer, D Serin, S Dolbeault, F Eisinger, C Roussel, JY Blay
doaj  

Screening mammography.

The Western journal of medicine, 1988
Breast cancer is the most commonly occurring cancer in women and, until recently surpassed by lung cancer, was the leading cause of cancer-related death in women. It is the leading cause of death in women aged 39 to 44 years. The American Cancer Society has estimated that there will be 135,000 new cases of breast cancer and 42,300 breast cancer-related
L L, Humphrey, D J, Ballard
openaire   +1 more source